Search

Viatris Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

17.82 2.24

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

17.8

Max

17.96

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-295M

-119M

Pardavimai

240M

3.8B

Pelnas, tenkantis vienai akcijai

0.69

Dividendų pajamingumas

2.83

Pelno marža

-3.162

Darbuotojai

30,000

EBITDA

9.4M

653M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+9.05% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

2.83%

2.25%

Kitas uždarbis

2026-11-05

Kitas dividendų mokėjimo data

2026-12-14

Kita Ex Dividend data

2026-11-23

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-890M

20B

Ankstesnė atidarymo kaina

15.58

Ankstesnė uždarymo kaina

17.82

Naujienos nuotaikos

By Acuity

100%

0%

300 / 339 reitingas Healthcare

Viatris Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-25 22:45; UTC

News

Viatris Inc is seeing a modest increase in after-market trading after filing a lawsuit against Novo Nordisk over its planned generic Wegovy.

2026-09-24 20:02; UTC

Viatris Inc is trading higher, reaching a peak cumulative return and positioned above its 20-day moving average during Thursday's session.

2026-09-23 20:07; UTC

News

Shares of Viatris Inc declined despite Oppenheimer initiating coverage with an Outperform rating and a $25 price target, amid broader market downward pressure.

2026-09-22 22:30; UTC

Viatris Inc is declining in after-market trading, moving lower since Tuesday's close despite peaking above the previous close earlier in the session.

2026-09-21 23:01; UTC

Viatris Inc is trading modestly higher in after-market hours, reaching a peak return since Monday's close and staying near the upper end of its one-month range.

2026-09-18 21:01; UTC

Viatris Inc. is trading modestly higher in after-market hours, currently positioned above its 20-day moving average and near the upper end of its one-month range.

2026-09-17 20:08; UTC

Viatris Inc. shares are up modestly, reaching a peak above the previous close while remaining above the 20-day moving average.

2026-09-16 23:16; UTC

Viatris Inc. is trading modestly lower in after-market hours, having experienced unusual volatility after initially rising earlier in the session.

2026-09-15 20:07; UTC

Viatris shares are roughly flat as the broader market declines amid a significant drop in the NY Empire State Manufacturing Index and rising oil prices.

2026-09-14 20:07; UTC

Viatris Inc's shares are higher today, continuing a gradual increase since Friday's close despite an earlier pullback. No specific news was identified.

2026-09-11 21:41; UTC

Shares of Viatris Inc. declined in after-market trading, reflecting a notable dip from earlier highs and a cumulative return of -0.36% since Friday's close.

2026-09-10 20:07; UTC

Viatris Inc shares are lower amid a broader market decline, reflecting ongoing economic concerns. The stock has seen five consecutive daily closes lower.

2026-09-09 19:36; UTC

News

Viatris shares are lower today despite Leerink Partners initiating coverage with an Outperform rating and a price target of $20.

2026-09-08 19:46; UTC

Viatris Inc shares are lower today, influenced by broader market declines and rising Brent crude prices amid geopolitical tensions. No specific company news was identified.

2026-09-04 22:14; UTC

Viatris Inc is gaining in after-market trading, rising above its 20-day moving average and reaching a session high since Friday's close.

2026-09-03 19:56; UTC

Viatris Inc is trading lower, reflecting broader market trends. The stock reached a session low earlier, with no specific news identified for the movement.

2026-09-02 19:46; UTC

Viatris Inc. shares are trading higher during Wednesday's session, remaining above the 20-day moving average amid rising U.S. Treasury yields.

2026-09-01 20:09; UTC

Viatris Inc shares are higher, supported by strength in the Pharmaceuticals sub-sector. Earlier, the stock pulled back from a session high.

2026-08-31 23:14; UTC

Shares of Viatris Inc. traded lower during after-market hours, reflecting broader market sentiment amid rising crude oil prices and geopolitical tensions.

2026-08-28 19:51; UTC

Viatris Inc shares are trading lower today, breaking a trend of higher daily closes. No specific news has been identified to explain the decline.

2026-08-27 23:02; UTC

Shares of Viatris Inc. traded lower in after-market hours. No specific company news was identified to explain the decline.

2026-08-26 23:01; UTC

Shares of Viatris Inc declined in after-market trading, dropping from a peak to a low following four consecutive sessions of gains. No specific news was identified.

2026-08-25 23:01; UTC

Viatris Inc shares are lower in after-market hours, reflecting a notable decline. The broader market initially showed strength but has since reversed some gains.

2026-08-24 19:56; UTC

Viatris Inc shares are higher today, continuing a positive trend since Friday. Broader market conditions include a significant drop in crude oil prices.

2026-08-21 23:01; UTC

Viatris Inc shares are lower in after-market hours, continuing a decline since Friday's close, with no specific news identified to explain the movement.

2026-08-20 20:06; UTC

Viatris Inc shares are declining amid broader market trends, remaining below their 20-day moving average. Earlier in the session, shares briefly upticked before pulling back.

2026-08-19 23:06; UTC

Viatris Inc. shares moved higher in after-market trading, despite remaining below the 20-day moving average and near the lower end of the one-month range.

2026-08-18 23:01; UTC

Viatris Inc shares rose in after-market trading, recovering from session lows. This increase comes amid broader market concerns over rising U.S. Treasury yields.

2026-08-17 23:16; UTC

Viatris Inc shares are trading higher in after-market hours, following earlier directional movement. No specific news was identified to explain the price action.

2026-08-14 20:06; UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

Akcijų palyginimas

Kainos pokytis

Viatris Inc Prognozė

Kainos tikslas

By TipRanks

9.05% į viršų

12 mėnesių prognozė

Vidutinis 19.444 USD  9.05%

Aukščiausias 25 USD

Žemiausias 13 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Viatris Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

9 ratings

5

Pirkti

3

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

300 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.